Skip to content
Open access

Momentum contrast-enhanced multimodal representation learning for drug synergy prediction

Jul 2026 · Bioinform. · Vol 42 · 0 citations · 30 references
Computer Science Medicine

Abstract

Abstract Motivation Accurate prediction of synergistic drug combinations can accelerate anticancer combination discovery. Existing methods inadequately model higher order drug–drug–cell-line interactions and drug–disease associations and remain sensitive to sparse and noisy multiomics data, limiting generalization to unseen cell lines and drug combinations. Results We present Momentum Contrast (MoCo)-MultiSynergy, a multimodal framework that combines modality-specific momentum contrastive learning with heterogeneous hypergraph modeling. The hypergraph represents synergistic drug–drug–cell-line triplets and drug–disease associations, while gated residual propagation refines node representations. MoCo modules regularize encoded drug and cell-line representations using latent feature masking and Gaussian perturbation. On the O’Neil and NCI-ALMANAC datasets, MoCo-MultiSynergy achieves the highest AUROC and AUPRC across the evaluated settings, with the largest gains when generalizing to unseen cell lines and drug combinations. Availability and implementation Source code is available at https://github.com/27167199/MoCo-MultiSynergy.

Read PDF

Similar papers

Open access Aug 2026

Multimodal contrastive learning for integrating molecular representations and cellular phenotypes in drug-target interaction prediction

A two-stage contrastive learning framework integrating drug structures, protein sequences, and Cell Painting morphological profiles into a unified embedding space, which reveals pathway-specific morphological signatures associated with drug targets, providing biologically interpretable insights into drug mechanisms.

Ying-Ju Lai, Tianyuzhou Liang, Po-Yuan Chen et al. · 0 citations
Aug 2026

Molecular Fragment-Based Graph Isomorphism Networks for Interpretable Prediction of Synergistic Drug Combinations.

Results indicate that FragSyn, through the synergistic design of fragment-level representation and cellular context awareness, provides an effective and interpretable new approach to synergistic drug combination prediction.

Li-Feng Shao, Jianqiang Sun, Hong-Zhan Ma et al. · 0 citations
Open access Aug 2026

NELLY enables patient-centric drug prioritization through interpretable drug-conditioned gene weighting

A translational framework combining patient-centric benchmarking with a pan-cancer pharmacogenomic atlas of patient-derived organoids and a deep learning model integrating transcriptomic and chemical information to predict drug response and prioritize therapies is introduced, supporting NELLY as a promising framework f...

C. Peralta Viteri, N. Harnischfeger, Lili Szabo et al. · 0 citations
Open access Aug 2026

Knowledge-driven multimodal mutual learning for cell line-targeted anticancer peptide prediction.

A hybrid dataset compiled from five well-established peptide databases is integrated and proposed, and the effectiveness of TargetPC is demonstrated, which outperforms the state-of-the-art baselines in terms of prediction accuracy, and maintains strong generalization to unseen ACPs and cell lines.

Xuan Liu, Jian Zhang, Chong-Yang Chen et al. · 0 citations
Aug 2026

MKASynergy: an adaptive method for drug synergy prediction via a mixture-of-experts kernel mechanism

MKASynergy, an adaptive drug synergy prediction method based on a mixture-of-experts kernel mechanism, achieves competitive predictive performance and visualization analysis confirms the model’s effectiveness in feature decoupling and helps interpret latent drug synergistic mechanisms.

Cundong Lin, Jiancheng Ni, Ying Yang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.